Back to search

Article

A compact glutamic acid decarboxylase 67 promoter enables inhibitory neuron-targeted AAV gene therapy for treatment-resistant epilepsy

2025-12-10

Abstract excerpt

<h4>ABSTRACT</h4> Epilepsy often becomes treatment-resistant, partly due to impaired inhibitory neurotransmission and reduced γ-aminobutyric acid (GABA) function. Enhancing inhibitory neuron activity via gene therapy may restore excitation–inhibition (E/I) balance. We developed a compact 410-bp glutamic acid decarboxylase 67 promoter (cmGAD67) that enables strong, selective transgene expression in inhibitory neur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e428107f-8454-5b4b-b7b1-33764e85ee49
DOI
10.64898/2025.12.07.692482
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A compact glutamic acid decarboxylase 67 promoter enables inhibitory neuron-targeted AAV gene therapy for treatment-resistant epilepsyDOI 10.64898/2025.12.07.692482
Select a neighboring publication to make it the new centre.